Niacinamide (No-Flush B3).

Niacinamide enters NAD synthesis through NAMPT while nicotinamide riboside enters through NRK phosphorylation. Both arrive at the same NAD pool by different, non-competing steps.

NMN is the intermediate niacinamide is converted into on the way to NAD. Supplying both loads the pathway upstream and one step later.

Tryptophan is converted to NAD through the kynurenine route, the only pathway that makes the ring rather than salvaging it. It adds to NAD supply independently of the niacinamide salvage step.

Kynureninase requires pyridoxal-5-phosphate, so the tryptophan to NAD route stalls when B6 is short and intermediates spill out instead. B6 keeps the de novo arm of NAD synthesis moving.

Kynurenine 3-monooxygenase is a flavin enzyme, and NAD kinase and the flavin-dependent dehydrogenases work alongside the nicotinamide pool. Riboflavin therefore serves both the making and the use of NAD.

Surplus nicotinamide is cleared as N-methylnicotinamide, which consumes methyl groups from SAM. A methyl donor keeps that methyl economy in balance during sustained niacinamide intake.

Folate-dependent remethylation restores the SAM pool that nicotinamide methylation draws down. It works on the same methyl budget from the supply side.

Nicotinamide N-methyltransferase uses SAM as its methyl source, so heavy niacinamide clearance pulls on SAM directly. The relationship is a documented draw, not an additive benefit.

Sirtuins consume NAD as their cosubstrate, and resveratrol raises sirtuin activity. Pairing them supplies the substrate for the enzyme being activated.

Pterostilbene is the dimethylated stilbene analogue acting on the same NAD-consuming sirtuin enzymes. Niacinamide supplies the NAD those enzymes draw on.

Nicotinamide N-methyltransferase clears excess nicotinamide by transferring a methyl group from SAM, producing N1-methylnicotinamide. Regenerating SAM runs through methionine synthase, which needs methylcobalamin as its cofactor. High nicotinamide intake therefore draws on the same methyl pool that B12 status supports, and the relationship holds in the other direction as well.

Choline is oxidised to betaine, which donates a methyl group to homocysteine through betaine-homocysteine methyltransferase and helps regenerate methionine and then SAM. Because nicotinamide clearance consumes SAM, methyl donor availability sits directly upstream of it. This is textbook one-carbon biochemistry.

SAM is formed from methionine and ATP, and it is the methyl donor that nicotinamide N-methyltransferase uses. Adequate methionine supply is therefore what makes nicotinamide clearance possible without draining the methyl pool. The dependency is enzymology and needs no trial.

Converting tryptophan to niacin runs through the kynurenine pathway, and several of its steps depend on iron-containing or iron-requiring enzymes alongside riboflavin and vitamin B6. Poor iron status slows that endogenous route, leaving dietary niacin more important. This is why B vitamin and mineral status interlock rather than acting separately.

Building NAD from nicotinamide requires phosphoribosyl transfer and adenylyl transfer steps that use ATP complexed with magnesium, and converting NAD to NADP through NAD kinase does the same. Magnesium is therefore an obligate partner in NAD synthesis rather than an optional one.

NADH generated by NAD-dependent dehydrogenases hands its electrons to complex I, which passes them to ubiquinone. Nicotinamide supports the NAD pool and CoQ10 sits at the next step in the same chain. The connection is a settled part of bioenergetics and is mechanistic rather than an outcome measured for the pair.

Pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase both use lipoamide and both reduce NAD to NADH as their final step. Nicotinamide supplies the NAD side of that chemistry. The two ingredients meet inside the same enzyme complexes.

Pantothenic acid is the precursor of coenzyme A, which carries acyl groups into the citric acid cycle, while NAD from nicotinamide accepts the electrons those oxidations release. Neither cofactor does useful work without the other. This is why the B vitamins are usually formulated together.

Thiamine pyrophosphate performs the decarboxylation step in pyruvate and alpha-ketoglutarate dehydrogenase, and NAD accepts the electrons at the end of the same reaction sequence. The two cofactors sit in the same multi-enzyme machine. Their pairing in B-complex products reflects that rather than convention alone.

Glycine acts as a methyl sink through glycine N-methyltransferase, buffering excess SAM. Nicotinamide clearance draws on the same SAM pool from the other side. In a formula carrying high-dose nicotinamide, methyl group supply and disposal both become relevant.

CD38 is a major NAD-consuming enzyme, and apigenin has been described as inhibiting it in cell and animal systems. Slowing NAD degradation while supplying a precursor is the rationale for pairing them. The work is preclinical and the effect has not been established in people.

Like apigenin, quercetin has been reported to inhibit CD38 in laboratory models, which would slow NAD breakdown. Combined with a precursor this is a supply-and-retention argument. It rests on preclinical work and on markers rather than on measured human outcomes.

NAMPT converts nicotinamide to nicotinamide mononucleotide, which NMNAT then adenylylates to NAD. This salvage route, not de novo synthesis from tryptophan, supplies most cellular NAD in humans. Anything labelled as an NAD support ingredient is working somewhere along this same short pathway.

Alcohol dehydrogenase is a zinc metalloenzyme that uses NAD as its electron acceptor, and several other zinc-dependent dehydrogenases work the same way. The metal and the cofactor are needed together for those reactions to run. This is enzymology, not a combination finding.

Cytochrome c oxidase is a copper-containing complex at the end of the chain that NADH feeds at the start. Both nutrients are needed for the chain to carry electrons through to oxygen. The link is mechanistic and sits several steps apart.

Inositol is frequently packaged alongside the B vitamins even though it is not one and humans synthesise it from glucose. Nothing in NAD biochemistry requires it. The pairing is formulation convention and is described here as such.

Thioredoxin reductase is a selenoenzyme that uses NADPH to keep thioredoxin reduced, and NADPH derives from NADP, which is made from NAD by NAD kinase. Nicotinamide sits at the head of that supply chain and selenium at the enzyme end. Both are needed for the antioxidant recycling loop to turn.

Regenerating reduced glutathione from its oxidised form requires NADPH, which comes from NADP built on the nicotinamide backbone. A depleted NADP pool slows glutathione recycling regardless of how much glutathione is present. The dependency is a settled part of redox biochemistry.